457 related articles for article (PubMed ID: 34790235)
1. Necroptosis-Related lncRNAs: Predicting Prognosis and the Distinction between the Cold and Hot Tumors in Gastric Cancer.
Zhao Z; Liu H; Zhou X; Fang D; Ou X; Ye J; Peng J; Xu J
J Oncol; 2021; 2021():6718443. PubMed ID: 34790235
[TBL] [Abstract][Full Text] [Related]
2. Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs.
Liu D; Xu S; Chang T; Ma S; Wang K; Sun G; Chen S; Xu Y; Zhang H
Front Immunol; 2022; 13():916800. PubMed ID: 35860239
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer.
Xiong X; Chen C; Li X; Yang J; Zhang W; Wang X; Zhang H; Peng M; Li L; Luo P
Front Oncol; 2023; 13():972558. PubMed ID: 37064115
[TBL] [Abstract][Full Text] [Related]
4. A five necroptosis-related lncRNA signature predicts the prognosis of bladder cancer and identifies hot or cold tumors.
Li H; Lv Z; Liu M
Medicine (Baltimore); 2023 Oct; 102(41):e35196. PubMed ID: 37832111
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Analysis of Necroptosis Landscape in Skin Cutaneous Melanoma for Appealing its Implications in Prognosis Estimation and Microenvironment Status.
Cao X; He J; Chen A; Ran J; Li J; Chen D; Zhang H
J Pers Med; 2023 Jan; 13(2):. PubMed ID: 36836481
[TBL] [Abstract][Full Text] [Related]
6. Integrated analysis of necroptosis-related lncRNAs for prognosis and immunotherapy of patients with pancreatic adenocarcinoma.
Mo J; Cui Z; Wang Q; Zhang W; Li J; Wu S; Qian W; Zhou C; Ma Q; Wang Z; Wu Z
Front Genet; 2022; 13():940794. PubMed ID: 36051690
[TBL] [Abstract][Full Text] [Related]
7. N7-methylguanosine-related lncRNAs: Predicting the prognosis and diagnosis of colorectal cancer in the cold and hot tumors.
Wu JY; Song QY; Huang CZ; Shao Y; Wang ZL; Zhang HQ; Fu Z
Front Genet; 2022; 13():952836. PubMed ID: 35937987
[No Abstract] [Full Text] [Related]
8. Necroptosis-associated long noncoding RNAs can predict prognosis and differentiate between cold and hot tumors in ovarian cancer.
He YB; Fang LW; Hu D; Chen SL; Shen SY; Chen KL; Mu J; Li JY; Zhang H; Yong-Lin L; Zhang L
Front Oncol; 2022; 12():967207. PubMed ID: 35965557
[TBL] [Abstract][Full Text] [Related]
9. A novel necroptosis-related lncRNA based signature predicts prognosis and response to treatment in cervical cancer.
Du X; Pu X; Wang X; Zhang Y; Jiang T; Ge Y; Zhu H
Front Genet; 2022; 13():938250. PubMed ID: 36561319
[No Abstract] [Full Text] [Related]
10. Construction of a Necroptosis-Associated Long Non-Coding RNA Signature to Predict Prognosis and Immune Response in Hepatocellular Carcinoma.
Wang W; Ye Y; Zhang X; Ye X; Liu C; Bao L
Front Mol Biosci; 2022; 9():937979. PubMed ID: 35911976
[No Abstract] [Full Text] [Related]
11. Deciphering the expression patterns of homologous recombination-related lncRNAs identifies new molecular subtypes and emerging therapeutic opportunities in epithelial ovarian cancer.
Hua T; Zhang XC; Wang W; Tian YJ; Chen SB
Front Genet; 2022; 13():901424. PubMed ID: 36246624
[TBL] [Abstract][Full Text] [Related]
12. A novel necroptosis-related lncRNA signature for predicting prognosis and immune response of colon cancer.
Luo J; Peng J; Xiao W; Huang S; Cao Y; Wang T; Wang X
Front Genet; 2022; 13():984696. PubMed ID: 36092933
[No Abstract] [Full Text] [Related]
13. Identification and Validation of a Novel Necroptosis-Related Long Noncoding RNA Prognostic Signature for Lung Adenocarcinoma.
Zeng C; Yu H; Liu X; Liu Q; Jin J
Biomed Res Int; 2022; 2022():9710540. PubMed ID: 36330457
[TBL] [Abstract][Full Text] [Related]
14. Necroptosis-related lncRNAs: establishment of a gene module and distinction between the cold and hot tumors in glioma.
Cao K; Su F; Shan X; Jiang X; Ni Z; Chen Y
Front Oncol; 2023; 13():1087117. PubMed ID: 37152037
[TBL] [Abstract][Full Text] [Related]
15. A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma.
Xie Y; Xu Z; Mei X; Shi W
Dis Markers; 2022; 2022():8232024. PubMed ID: 36438905
[TBL] [Abstract][Full Text] [Related]
16. Construction of a novel necroptosis-related lncRNA signature for prognosis prediction in esophageal cancer.
Liu Y; Hao H; Kang L; Zheng G; Guo X; Li B; Zhao H; Hao H
BMC Gastroenterol; 2022 Jul; 22(1):345. PubMed ID: 35840890
[TBL] [Abstract][Full Text] [Related]
17. A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma.
Lu Y; Luo X; Wang Q; Chen J; Zhang X; Li Y; Chen Y; Li X; Han S
Front Genet; 2022; 13():862741. PubMed ID: 35368663
[No Abstract] [Full Text] [Related]
18. Screening and validation of platelet activation-related lncRNAs as potential biomarkers for prognosis and immunotherapy in gastric cancer patients.
Yuan M; Jia Y; Xing Y; Wang Y; Liu Y; Liu X; Liu D
Front Genet; 2022; 13():965033. PubMed ID: 36186426
[No Abstract] [Full Text] [Related]
19. A Novel Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response of Glioma.
Wu Z; Liu M; Fu J; Li J; Qin L; Wu L; Chen H; Yan X; Liu Q; Zheng J
Biomed Res Int; 2022; 2022():3742447. PubMed ID: 35757472
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of necroptosis-related long noncoding RNA to predict prognosis, immune status, and immunotherapeutic response in clear cell renal cell carcinoma.
Tang H; Chen H; Yuan H; Jin X; Chen G
Transl Cancer Res; 2022 Dec; 11(12):4254-4271. PubMed ID: 36644185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
